RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement
mRNA vaccines have amassed a strong interest from scientists and nonscientists alike for their potential in treating cancer and curbing the spread of infectious diseases. Their success has been bolstered by the COVID-19 pandemic as mRNA vaccines for the SARS-CoV-2 virus showed unrivaled efficiency a...
Guardado en:
Autores principales: | Hana M. Abdelzaher, Asmaa S. Gabr, Basma M. Saleh, Rana M. Abdel Gawad, Ahmed A. Nour, Anwar Abdelanser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd30f1118b8b40a88168d097a0574fe3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
por: Krzysztof Lukaszuk, et al.
Publicado: (2021) -
Evaluation of a new vaccine against Staphylococcus aureus mastitis in dairy herds of southern Chile. I. Challenge trial
por: Mella,Armin, et al.
Publicado: (2017) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
por: Bruna Aparecida Souza Machado, et al.
Publicado: (2021) -
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Piotr Rzymski, et al.
Publicado: (2021) -
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Chin-Shern Lau, et al.
Publicado: (2021)